8-K: Select Medical Corporation Prices $550 Million Senior Notes Offering to Refinance Debt
Debt Offering Announcement
Select Medical Corporation has priced a $550 million private offering of senior notes due 2032 to refinance existing debt and redeem outstanding notes.
Summary
- Select Medical Corporation, a subsidiary of Select Medical Holdings Corporation, has priced a private offering of $550 million in senior notes due 2032.
- The notes will carry a 6.250% interest rate and are expected to close on December 3, 2024, subject to customary closing conditions.
- The proceeds from this offering, along with a new $1.05 billion incremental term loan and available cash, will be used to refinance existing term loans and redeem all outstanding 6.250% senior notes due in 2026.
- The company also intends to amend its existing senior secured credit agreement to extend the maturity date of its revolving credit facility and provide for an incremental revolving commitment of $50 million.
- The notes are being offered to qualified institutional buyers under Rule 144A and to non-U.S. persons in compliance with Regulation S of the Securities Act.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as the company is proactively managing its debt, but there are risks associated with increased leverage and interest rates.
Positives
- The refinancing will allow Select Medical to extend its debt maturities.
- The company is taking advantage of the debt markets to optimize its capital structure.
- The new term loan and revolving commitment provide additional financial flexibility.
Negatives
- The company is taking on additional debt, which increases its leverage.
- The interest rate on the new notes is 6.250%, which may be higher than previous debt.
Risks
- The closing of the offering is subject to customary closing conditions, which may not be met.
- The company's ability to execute the refinancing plan depends on market conditions and investor demand.
- There are risks associated with the company's ability to manage its increased debt load.
Future Outlook
The company intends to use the proceeds from the offering and the new term loan to refinance existing debt and redeem outstanding notes, which is expected to improve its financial position.
Management Comments
- Select Medical Holdings Corporation announced that Select Medical Corporation has priced a private offering of $550 million in aggregate principal amount of its 6.250% senior notes due 2032.
- Select intends to use the net proceeds of the Offering, together with the proceeds from the proposed new incremental term loan and cash on hand, to repay in full the term loans currently outstanding under Selects existing senior secured credit agreement, to redeem all of Selects outstanding 6.250% senior notes due 2026 and to pay fees and expenses related to the foregoing.
Industry Context
This announcement reflects a common strategy in the healthcare industry to manage debt and optimize capital structures, especially in a rising interest rate environment. Companies often refinance debt to extend maturities and reduce interest costs.
Comparison to Industry Standards
- Many healthcare companies use debt financing to fund operations and acquisitions, similar to Select Medical's approach.
- The interest rate of 6.250% on the senior notes is within the typical range for corporate debt of this type, but may be higher than previous debt due to the current interest rate environment.
- The use of a combination of senior notes, term loans, and revolving credit facilities is a standard practice for companies with significant capital needs.
- Companies like HCA Healthcare and Tenet Healthcare also frequently access debt markets to manage their capital structure.
Stakeholder Impact
- Shareholders may see a positive impact from the improved capital structure.
- Creditors will be impacted by the refinancing of existing debt.
- Employees are unlikely to be directly impacted by this transaction.
Next Steps
- The offering is expected to close on December 3, 2024, subject to customary closing conditions.
- The company will use the proceeds to refinance existing debt and redeem outstanding notes.
- The company will amend its existing senior secured credit agreement.
Key Dates
| Date | Description |
|---|---|
| 2017-03-06 | Date of the original Credit Agreement. |
| 2024-11-18 | Date of the Purchase Agreement and pricing of the senior notes offering. |
| 2024-12-03 | Expected closing date of the senior notes offering and the new credit agreement. |
Keywords
senior notes, debt offering, refinancing, term loan, credit agreement, Select Medical, Rule 144A, Regulation S, capital structure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.